Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition that is
believed to affect> 25% of adults worldwide. Unless specific testing is done to identify …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with insulin
resistance and metabolic syndrome. The spectrum of disease ranges from simple steatosis …

Nonalcoholic fatty liver disease (NAFLD) is a very common cause of chronic liver disease in
the United States. A large proportion of patients with NAFLD have coexisting metabolic …

Nonalcoholic fatty liver disease (NAFLD), the most common of chronic liver disease in
Western Country, is closely related to insulin resistance and oxidative stress and includes a …

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and includes a spectrum of
abnormalities ranging from steatosis to cirrhosis. In this review, we address recent evidence …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is rising. NAFLD/nonalcoholic
steatohepatitis (NASH) is associated not only with hepatic morbidity and mortality but also …

Nonalcoholic fatty liver disease (NAFLD) is prevalent in people with the metabolic syndrome
and type 2 diabetes and is present in up to one‐third of the general population. Evidence is …

Non-alcoholic fatty liver disease (NAFLD) is present in up to one-third of the general
population and in the majority of patients with cardio-metabolic risk factors such as …

Nonalcoholic fatty liver disease (NAFLD), also named metabolic dysfunction-associated fatty
liver disease (MAFLD), is a progressive disease spectrum encompassing simple steatosis …

Non-alcoholic fatty liver disease (NAFLD) has become one of the most frequent chronic liver
diseases in the Western society and its prevalence is likely to rise even further. An …